Zanidatamab | World Briefings
Advertise with us
Subscribe
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

Zanidatamab

Explore All Zanidatamab News and Updates Here
Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer

World

17 Sep, 2024
Maria Garcia

Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer

Jazz Pharmaceuticals has posted fresh phase 2 data on zanidatamab that show the HER2-targeted bispecific antibody kept 59% of people...

News Categories
Follow Us
Newsletter
Subscribe to Newsletter

Stay Tuned With Updates